Assessing developmental osteotoxicity of chlorides in the embryonic stem cell test

Reproductive Toxicology

Volumn 30, Issue 2, 2010, Pages 277-283

  zur Nieden, Nicole I ^a,b   Baumgartner, Laura ^a  

^a FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alternative test method; Chloride; Embryonic stem cell test; Osteogenesis

Indexed keywords

ALUMINUM CHLORIDE; LITHIUM CHLORIDE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CALCIFICATION; CELL DIFFERENTIATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; EMBRYONIC STEM CELL; FETUS DEVELOPMENT; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PREDICTION; TOXICITY TESTING;

MURINAE;

EID: 77955271208     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.04.014     Document Type: Article

References (63)

1. Verkman A.S. Development and biological applications of chloride sensitive fluorescent indicators. Am J Physiol Cell Physiol 1990, 259:C375-C388.
2. Greeley A. A pinch of controversy shakes up dietary salt 1997, http://www.fda.gov/fdac/features/1997/797_salt.html.
3. MacGregor G.A. Salt-more adverse effects. Am J Hypertens 1997, 10:37S-41S.
4. Jones G., Beard T., Parameswaran V., Greenaway T., von Witt R. A population-based study of the relationship between salt intake, bone resorption and bone mass. Eur J Clin Nutr 1997, 51:561-565.
5. Devine A., Criddle R.A., Dick I.M., Kerr D.A., Prince R.L. A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr 1995, 62(4):740-745.
6. Frassetto L.A., Morris R.C., Sebastian A. Dietary sodium as a determinant of bone resorption rate and bone mineral density in postmenopausal women. J Am Soc Nephrol 2004, 15:512A.
7. National Research Council, Commission on Life Sciences Recommended dietary allowances. Subcommittee on the Tenth Edition of the RDAs Food and Nutrition Board 1989.
8. Lovitch D., Christianson M.L. Osteogenesis from cultured chick periostea has a specific requirement for chloride. J Bone Miner Res 2000, 15(8):1620-1629.
9. Szabo K.T. Teratogenic effect of lithium carbonate in the foetal mouse. Nature 1970, 225:73-75.
10. Marathe M.R., Thomas G.P. Embryotoxicity and teratogenicity of lithium carbonate in Wistar rat. Toxicol Lett 1986, 34:115-120.
11. Hoberman A.L., Deprospo J.R., Lochry E.A., Christian M.S. Developmental toxicity study of orally administered lithium hypochlorite in rats. J Am Coll Toxicol 1990, 9:367-379.
12. Jacobson S.J., Jones K., Johnson K., Ceolin L., Kaur P., Sahn D., et al. Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992, 339:530-533.
13. Talbot J.H. Use of lithium salts as a substitute for sodium chloride. Arch Intern Med (Chic) 1950, 85(1):1-10.
14. Hanlon L.W., Romaine M., Gilroy F.J. Lithium chloride as a substitute for sodium chloride in the diet; observations on its toxicity. J Am Med Assoc 1949, 139(11):688-692.
15. Schou M., Amdisen A. Lithium and placenta. Am J Obstet Gynecol 1975, 122:541.
16. Tannirandorn P., Epstein S. Drug-induced bone loss. Osteoporos Int 2000, 11(8):637-659.
17. Usami M., Sakemi K., Tsuda M., Ohno Y. Teratogenicity study of magnesium chloride hexahydrate in rats. Eisei Shikenjo Hokoku 1996, 114:16-20.
18. Tanaka H., Hagiwara A., Kurata Y., Ogiso T., Futakuchi M., Ito N. Thirteen-week oral toxicity study of magnesium chloride in B6C3F1 mice. Toxicol Lett 1994, 73(1):25-32.
19. Jeffery E.H., Abreo K., Burgess E., Cannata J., Greger J.L. Systemic aluminum toxicity: effects on bone, hematopoietic tissue, and kidney. J Toxicol Environ Health 1996, 48(6):649-665.
20. Severson A.R., Haut C.F., Firling C.E., Huntley T.E. Influence of short-term aluminum exposure on demineralized bone matrix induced bone formation. Arch Toxicol 1992, 66(10):706-712.
21. zur Nieden N.I., Kempka G., Ahr H.J. Molecular multiple endpoint embryonic stem cell test-a possible approach to test for the teratogenic potential of compounds. Toxicol Appl Pharmacol 2004, 194:257-269.
22. Smith A.G., Heath J.K., Donaldson D.D., Wong G.G., Moreau J., Stahl M., et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988, 336(6200):688-690.
23. Odorico J.S., Kaufman D.S., Thomson J.A. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001, 19(3):193-204.
24. Buttery L.D., Bourne S., Xynos J.D., Wood H., Hughes F.J., Hughes S.P., et al. Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells. Tissue Eng 2001, 7(1):89-99.
25. zur Nieden N.I., Kempka G., Ahr H.J. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 2003, 71(1):18-27.
26. Yamane T., Kunisada T., Yamazaki H., Era T., Nakano T., Hayashi S.I. Development of osteoclasts from embryonic stem cells through a pathway that is c-fms but not c-kit dependent. Blood 1997, 90(9):3516-3523.
27. Spielmann H., Pohl I., Doering B., Liebsch M., Moldenhauer F. The embryonic stem cell test (EST), an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In vitro Toxicol 1997, 10:119-127.
28. zur Nieden N.I., Ruf L.J., Kempka G., Hildebrand H., Ahr H.J. Molecular markers in embryonic stem cells. Toxicol In Vitro 2001, 15:455-461.
29. zur Nieden N.I., Price F.D., Davis L.A., Everitt R.E., Rancourt D.E. Gene profiling on mixed embryonic stem cell populations reveals a biphasic role for beta-catenin in osteogenic differentiation. Mol Endocrinol 2007, 21(3):674-685.
30. zur Nieden N.I., Cormier J.T., Kallos M.S., Rancourt D.E. Murine embryonic stem cells maintain pluripotency after long-term culture in suspension bioreactors. J Biotechnol 2007, 129(3):421-432.
31. Schou M. Note on the start of the Scandinavian register of lithium babies. Acta Psychiat Scand 1969, 207:96-97.
32. Schmidt M.M., Guan K., Wobus A.M. Lithium influences differentiation and tissue-specific gene expression of mouse embryonic stem (ES) cells in vitro. Int J Dev Biol 2001, 45(2):421-429.
33. Bigot K., De Lange J., Archer J., Clothier R., Bremer S. The relative semi-quantification of mRNA expression as a useful toxicological endpoint for the identification of embryotoxic/teratogenic substances. Toxicol In Vitro 1999, 13:619-623.
34. Bremer S., van Dooren M., Paparella M., Kolossov E., Fleischmann B., Hescheler J. Establishment of an in vitro embryotoxicity assay with green-fluorescent protein-expressing embryonic cell-derived cardiomyocytes. ATLA 1999, 27:471-484.
35. Genschow E., Spielmann H., Scholz G., Pohl I., Seiler A., Clemann N., et al. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests. Altern Lab Anim 2004, 32(3):209-244.
36. Spielmann H. The way forward in reproductive/developmental toxicity testing. Altern Lab Anim 2009, 37(6):641-656.
37. Lindsley R.C., Gill J.G., Kyba M., Murphy T.L., Murphy K.M. Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm. Development 2006, 133(19):3787-3796.
38. Rodda S.J., McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133(16):3231-3244.
39. Hill T.P., Taketo M.M., Birchmeier W., Hartmann C. Multiple roles of mesenchymal beta-catenin during murine limb patterning. Development 2006, 133(7):1219-1229.
40. Davis L.A., Zur Nieden N.I. Mesodermal fate decisions of a stem cell: the Wnt switch. Cell Mol Life Sci 2008, 65(17):2658-2674.
41. Yang J.Y., Jung J.Y., Cho S.W., Choi H.J., Kim S.W., Kim S.Y., et al. Chloride intracellular channel 1 regulates osteoblast differentiation. Bone 2009, 45(6):1175-1185.
42. Maki M., Miyazaki H., Nakajima K., Yamane J., Niisato N., Morihara T., et al. Chloride-dependent acceleration of cell cycle via modulation of Rb and cdc2 in osteoblastic cells. Biochem Biophys Res Commun 2007, 361(4):1038-1043.
43. - transporter/channels diminish proliferation of osteoblastic cells. Biomed Res 2009, 30(2):137-140.
44. Niisato N., Van Driessche W., Liu M., Marunaka Y. Involvement of protein tyrosine kinase in osmoregulation of Na+ transport and membrane capacitance in renal A6 cells. J Membr Biol 2000, 175:63-77.
45. Cheng H.F., Wang J.L., Zhang M.Z., McKanna J.A., Harris R.C. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest 2000, 106:681-688.
46. Yang T., Park J.M., Arend L., Huang Y., Topaloglu R., Pasumarthy A., et al. Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line. J Biol Chem 2000, 275:37922-37929.
47. Forwood M.R. Inducible cyclo-oxygenase (COX2) mediates the induction of bone formation by mechanical loading in vivo. J Bone Miner Res 1996, 11:1688-1693.
48. Kim S.J., Im D.S., Kim S.H., Ryu J.H., Hwang S.G., Seong J.K., et al. Beta-catenin regulates expression of cyclooxygenase-2 in articular chondrocytes. Biochem Biophys Res Commun 2002, 296:221-226.
49. Norvell S.M., Alvarez M., Bidwell J.P., Pavalko F.M. Fluid shear stress induces beta-catenin signaling in osteoblasts. Calcif Tissue Int 2004, 75(5):396-404.
50. - concentration. EMBO J 2001, 2:1047-1051.
51. i. Am J Physiol Cell Physiol 1994, 266:C1440-C1452.
52. i-Dependent phosphorylation of the Na-K-Cl cotransport protein of dog tracheal epithelial cells. J Biol Chem 1995, 270:28955-28961.
53. Putney L.K., Vibat C.R., O'Donnell M.E. Intracellular Cl regulates Na-K-Cl cotransport activity in human trabecular meshwork cells. Am J Physiol Cell Physiol 1999, 277:C373-C383.
54. Zanello L.P., Norman A. 1alpha,25(OH)2 vitamin D3 actions on ion channels in osteoblasts. Steroids 2006, 71(4):291-297.
55. Zanello L.P., Norman A.W. 1alpha,25(OH)2 Vitamin D3-mediated stimulation of outward anionic currents in osteoblast-like ROS 17/2.8 cells. Biochem Biophys Res Commun 1996, 225:551-556.
56. Zanello L.P., Norman A.W. Electrical responses to 1alpha,25(OH)2-vitamin D3 and their physiological significance in osteoblasts. Steroids 2004, 69:561-565.
57. Blair H.C., Teitelbaum S.L., Ghiselli R., Gluck S. Osteoclastic bone resorption by a polarized vacuolar proton pump. Science 1989, 245:855-857.
58. al Awqati Q. Chloride channels of intracellular organelles. Curr Opin Cell Biol 1995, 7:504-508.
59. Schaller S., Henriksen K., Sveigaard C., Heegaard A.M., Hélix N., Stahlhut M., et al. The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation. J Bone Miner Res 2004, 19(7):1144-1153.
60. Campos-Xavier A.B., Saraiva J.M., Ribeiro L.M., Munnich A., Cormier-Daire V. Chloride channel 7 (CLCN7) gene mutations in intermediate autosomal recessive osteopetrosis. Hum Genet 2003, 112:186-189.
61. Kornak U., Kasper D., Bosl M.R., Kaiser E., Schweizer M., Schulz A., et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001, 104:205-215.
62. Wedig K.E., Kogan J., Schorry E.K., Whitsett J.A. Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol 2006, 26(6):371-374.
63. Firling C.E., Hill T.A., Severson A.R. Aluminum toxicity perturbs long bone calcification in the embryonic chick. Arch Toxicol 1999, 73(7):359-366.